Impact of RDN-led Medication Therapy Trial on Type 2 Diabetes Outcomes

Recorded Webinar

This webinar describes a randomized controlled trial that investigated the effectiveness of an RDN-led telemedicine program vs. a control group on diabetes optimal care goals in rural primary care practices.

  • SKU WEBDCEIRDNLMTTDO0919
DPG Member Price
$0.00
Member Price
$40.00
Nonmember Price
$40.00

This webinar was presented live on September 24, 2019.

Collaborative, team-based models that maximize skills of different disciplines may improve care for individuals with diabetes, but few have been tested using rigorous research designs. This webinar describes a randomized controlled trial that investigated the effectiveness of a registered dietitian nutritionist-led telemedicine program versus a control group on diabetes optimal care goals in two rural Minnesota primary care practices.

Registered dietitian nutritionists utilized an approved treatment protocol to initiate/titrate medication therapies for blood glucose, hypertension and lipids, in addition to providing medical nutrition therapy for those assigned to the intervention group. RDNs effectively implemented the medication protocol and medication nutrition therapy to deliver positive health outcomes. The speakers will start out by sharing some context of their population health work, including a primary prevention program that led to the development of the type 2 diabetes trial.

  • CPEU: 1.0
  • CPE Level: 1

Learning Objectives

  1. Identify potential benefits of utilizing a telehealth program in a rural community
  2. Describe at least 3 steps in implementing a facility-based medication protocol
  3. Discuss the benefits of utilizing integrated teams to maximum potential

Presenters

Gretchen Benson, RDN, LDN, CDE
Population Health Program Manager
Minneapolis Heart Institute Foundation

Joy Hayes, MS, RDN, LDN,CDE
Population Health Specialist
Minneapolis Heart Institute Foundation

  • SKU WEBDCEIRDNLMTTDO0919